The article discusses the transformation of HIV from an acute, life-threatening illness to a chronic disease due to the success of antiretroviral therapy (ART). While ART has significantly improved health outcomes and extended life expectancy, it does not fully restore immune health, leading to new complications such as cardiovascular disease, cancer, and metabolic disorders. These complications, referred to as "non-AIDS morbidity," are increasingly prevalent and pose challenges for healthcare systems, especially in resource-limited regions. The article highlights the need for a global effort to find a cure for HIV, as current treatments are not sufficient to address the long-term health issues associated with chronic HIV infection. It also emphasizes the importance of addressing the aging of the HIV population, which will lead to a higher burden of comorbidities. The article discusses the persistence of HIV despite effective ART, the role of inflammation and immune activation in disease progression, and the potential for new treatments to reduce these effects. It concludes with the need for improved healthcare systems and research to manage the long-term impact of HIV as a chronic disease.The article discusses the transformation of HIV from an acute, life-threatening illness to a chronic disease due to the success of antiretroviral therapy (ART). While ART has significantly improved health outcomes and extended life expectancy, it does not fully restore immune health, leading to new complications such as cardiovascular disease, cancer, and metabolic disorders. These complications, referred to as "non-AIDS morbidity," are increasingly prevalent and pose challenges for healthcare systems, especially in resource-limited regions. The article highlights the need for a global effort to find a cure for HIV, as current treatments are not sufficient to address the long-term health issues associated with chronic HIV infection. It also emphasizes the importance of addressing the aging of the HIV population, which will lead to a higher burden of comorbidities. The article discusses the persistence of HIV despite effective ART, the role of inflammation and immune activation in disease progression, and the potential for new treatments to reduce these effects. It concludes with the need for improved healthcare systems and research to manage the long-term impact of HIV as a chronic disease.